michigan glp-1 law firm pancreatitis in GLP-1 Agonists and Pancreatitis Risk About 1 — The K-12
Description
Eli Lilly makes the best-selling GLP-1 drug, and sales are accelerating.
Metabolic dysfunction-associated steatotic liver disease (MASLD) and chronic kidney disease (CKD) pose substantial global health challenges
Background Establishing whether there is a potential relationship between glucagon-like peptide 1 receptor agonists (GLP-1RAs) and suicidal or self-injurious behaviors (SSIBs) is crucial for public safety
Whilst Liver physicians / hepatologists may be unfamiliar with using semaglutide, weight loss and better glycaemic control would be valuable for a substantial proportion of patients
